There are also studies demonstrating that overexpression of ACE2 or infusion of recombinant ACE2 can improve vascular dysfunction and atherosclerosis, but there are no studies on AAA.97, 98, 99, 100, 101, 102. The gene discussed is ACE2; the disease is triple-A syndrome.